John Ruffolo - Net Worth and Insider Trading

John Ruffolo Net Worth

The estimated net worth of John Ruffolo is at least $1,480 dollars as of 2024-06-06. John Ruffolo is the Director of NervGen Pharma Corp and owns about 827 shares of NervGen Pharma Corp (TSXV:NGEN) stock worth over $1,480. Details can be seen in John Ruffolo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Ruffolo has not made any transactions after 2024-02-14 and currently still holds the listed stock(s).

Transaction Summary of John Ruffolo

To

John Ruffolo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Ruffolo owns 1 companies in total, including NervGen Pharma Corp (TSXV:NGEN) .

Click here to see the complete history of John Ruffolo’s form 4 insider trades.

Insider Ownership Summary of John Ruffolo

Ticker Comapny Transaction Date Type of Owner
TSXV:NGEN NervGen Pharma Corp 2024-02-14 Director

John Ruffolo Latest Holdings Summary

John Ruffolo currently owns a total of 1 stock. John Ruffolo owns 827 shares of NervGen Pharma Corp (TSXV:NGEN) as of February 14, 2024, with a value of $1,480.

Latest Holdings of John Ruffolo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSXV:NGEN NervGen Pharma Corp 2024-02-14 827 1.79 1,480

Holding Weightings of John Ruffolo


John Ruffolo Form 4 Trading Tracker

According to the SEC Form 4 filings, John Ruffolo has made a total of 2 transactions in NervGen Pharma Corp (TSXV:NGEN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NervGen Pharma Corp is the acquisition of 406 shares on February 14, 2024, which cost John Ruffolo around $1,198.

Insider Trading History of John Ruffolo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Ruffolo Trading Performance

GuruFocus tracks the stock performance after each of John Ruffolo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Ruffolo is -34.05%. GuruFocus also compares John Ruffolo's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Ruffolo within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Ruffolo's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Ruffolo

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.71 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -14.59 LIMIT LIMIT LIMIT LIMIT LIMIT

John Ruffolo Ownership Network

Ownership Network List of John Ruffolo

No Data

Ownership Network Relation of John Ruffolo

Insider Network Chart

John Ruffolo Owned Company Details

What does NervGen Pharma Corp do?

Who are the key executives at NervGen Pharma Corp?

John Ruffolo is the Director of NervGen Pharma Corp. Other key executives at NervGen Pharma Corp include 10% Security Holder & Director Harold Punnett , and Senior Officer Robert Pilz .

NervGen Pharma Corp (TSXV:NGEN) Insider Trades Summary

Over the past 18 months, John Ruffolo made 2 insider transaction in NervGen Pharma Corp (TSXV:NGEN) with a net purchase of 827. Other recent insider transactions involving NervGen Pharma Corp (TSXV:NGEN) include a net purchase of 2,000 shares made by Krista McKerracher , a net sale of 1,000 shares made by William Joseph Radvak ,

In summary, during the past 3 months, insiders sold 0 shares of NervGen Pharma Corp (TSXV:NGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000 shares of NervGen Pharma Corp (TSXV:NGEN) were sold and 2,827 shares were bought by its insiders, resulting in a net purchase of 1,827 shares.

NervGen Pharma Corp (TSXV:NGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NervGen Pharma Corp Insider Transactions

No Available Data

John Ruffolo Mailing Address

Above is the net worth, insider trading, and ownership report for John Ruffolo. Currently GuruFocus does not have mailing address information for John Ruffolo.

Discussions on John Ruffolo

No discussions yet.